A Highly Efficient Human Pluripotent Stem Cell Microglia Model Displays a Neuronal-Co-culture-Specific Expression Profile and Inflammatory Response.
Haenseler W, Sansom SN, Buchrieser J, Newey SE, Moore CS, Nicholls FJ, Chintawar S, Schnell C, Antel JP, Allen ND, Cader MZ, Wade-Martins R, James WS, Cowley SA. · 2017
Read A Highly Efficient Human Pluripotent Stem Cell Microglia Model Displays a Neuronal-Co-culture-Specific Expression Profile and Inflammatory Response. by Haenseler W, Sansom SN, Buchrieser J, Newey SE, Moore CS, Nicholls FJ, Chintawar S, Schnell C, Antel JP, Allen ND, Cader MZ, Wade-Martins R, James WS, Cowley SA. (2017) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5470330.txt.
Introduction
Haenseler and co-authors report a methods study in Stem Cell Reports. They build a lab model of human microglia, the immune cells of the brain. Microglia are tied to diseases such as Alzheimer's and Parkinson's. Fresh human microglia are hard to obtain, though. The team seeks a faithful model that grows well in the lab.
The method starts with stem cells and turns them into macrophage-like cells. Those cells then grow beside stem-cell-derived cortical neurons. In that shared culture, the microglia show key marker genes and branching shapes. They also eat particles and respond to activation signals. The authors report that shared culture beats solo culture for realism.
Catalog record
| CREATOR | Haenseler W, Sansom SN, Buchrieser J, Newey SE, Moore CS, Nicholls FJ, Chintawar S, Schnell C, Antel JP, Allen ND, Cader MZ, Wade-Martins R, James WS, Cowley SA. |
|---|---|
| YEAR | 2017 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 57 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
A Highly Efficient Human Pluripotent Stem Cell Microglia Model Displays a Neuronal-Co-culture-Specific Expression Profile and Inflammatory Response By Walther Haenseler, Stephen N Sansom, Julian Buchrieser, Sarah E Newey, Craig S Moore, Francesca J Nicholls, Satyan Chintawar, Christian Schnell, Jack P Antel, Nicholas D Allen, M Zameel Cader, Richard Wade-Martins Published in: Stem Cell Reports DOI: 10.1016/j.stemcr.2017.05.017 ABSTRACT Summary Microglia are increasingly implicated in brain pathology, particularly neurodegenerative disease, with many genes implicated in Alzheimer's, Parkinson's, and motor neuron disease expressed in microglia. There is, therefore, a need for authentic, efficient in vitro models to study human microglial pathological mechanisms. Microglia originate from the yolk sac as MYB-independent macrophages, migrating into the developing brain to complete differentiation. Here, we recapitulate microglial ontogeny by highly efficient differentiation of embryonic MYB-independent iPSC-derived macrophages then co-culture them with iPSC-derived cortical neurons. Co-cultures retain neuronal maturity and functionality for many weeks. Co-culture microglia express key microglia-specific markers and neurodegenerative disease-relevant genes, develop highly dynamic ramifications, and are phagocytic. Upon activation they become more ameboid, releasing multiple microglia-relevant cytokines. Importantly, co-culture microglia downregulate pathogen-response pathways, upregulate homeostatic function pathways, and promote a more anti-inflammatory and pro-remodeling cytokine response than corresponding monocultures, demonstrating that co-cultures are preferable for modeling authentic microglial physiology. Keywords: human, induced pluripotent stem cell, iPSC, macrophage, microglia, cortical neurons, neuroinflammation, neurodegeneration, Alzheimer's disease, Parkinson's disease INTRODUCTION Microglia are brain-resident macrophages, with important homeostatic functions that provide a supportive environment to neurons. This includes pruning incompetent synapses during development, and clearance of dead cells, misfolded proteins, and other cellular debris (Ransohoff, 2016). However, they can become activated by inflammatory stimuli, producing a battery of cytokines, including the potentially damaging tumor necrosis factor α (TNFα). If not satisfactorily resolved, this response can lead to a chronically damaging cycle of activation and neuronal destruction. Numerous genes associated with Alzheimer's disease (AD), Parkinson's disease (PD), motor neuron disease/amyotrophic lateral sclerosis (MND/ALS), and frontotemporal dementia (FTD) are expressed in microglia, including TREM2, CD33, LRRK2, and C9orf72 (O'Rourke et al., 2016, Russo et al., 2014, Villegas-Llerena et al., 2016), prompting a growing interest in microglia biology and their relevance to neurodegenerative disease. Study of microglia has been largely restricted to non-human models (mostly mouse), since availability of fresh primary human microglia is very limited and they cannot be propagated. Moreover, microglia rapidly lose their unique identity when removed from the brain environment and cultured in monoculture in vitro (Butovsky et al., 2014). Transformed microglial-like cell lines are by definition highly proliferative and therefore not a good model for understanding a predominantly non-proliferating, differentiated cell type. There is therefore a need for practical, authentic human microglial cellular models. However, only recently has the ontogeny of microglia been established to inform appropriate modeling. In mice, two waves of embryonic macrophages are produced in the yolk sac blood islands at embryonic day 7.5 (E7.5) and E8.25, and the first wave migrate into the developing brain and differentiate to microglia (Ginhoux et al., 2010, Gomez Perdiguero et al., 2015, Hoeffel et al., 2015, Palis et al., 1999). These yolk sac-derived macrophages are Myb independent but dependent on PU.1 and Irf8 (Kierdorf et al., 2013, Schulz et al., 2012). Hematopoietic stem cells (HSCs), in contrast, derive from the aorto-gonado-mesonephros region at day E10.5, populate the fetal liver and bone marrow, and give rise to adult blood cells from HSCs in bone marrow niches, which are dependent on Myb for their renewal. Myb independence, therefore, distinguishes yolk sac-derived macrophages from adult, definitive, blood monocyte-derived macrophages. Microglia in the developing brain proliferate locally at a low rate and are not normally replaced by other monocytes and macrophages from outside the brain, in contrast to most other tissue-resident macrophages (which also initially originate from yolk sac-derived macrophages, but are partially or fully replaced by fetal liver- or blood monocyte-derived macrophages [Bain et al., 2014, Calderon et al., 2015, Epelman et al., 2014, Guilliams et al., 2014, Hoeffel and Ginhoux, 2015, Tamoutounour et al., 2013]). In the brain, interleukin-34 (IL-34) is an alternative CSF1R ligand supporting microglia survival and differentiation (Greter et al., 2012), and microglia adopt an increasingly ramified morphology and continued maturation far beyond birth. In humans there are few opportunities to investigate the ontogeny of microglia, but it is assumed that the processes are analogous to those in mice. Yolk sac-derived macrophages appear at E17 (Tavian and Peault, 2005), enter the brain from E31 onward (Rezaie et al., 2005, Monier et al., 2007), and mature together with neurons to fully functional ramified microglia (Figure 1A). Human cortical neurons show spontaneous electrical activity after microglia invasion, from gestation week 20 onwards (Moore et al., 2011). [Figure: iPSC-Derived Microglia-Neuron Co-culture Recapitulates Microglial Development in the Embryo(A) Human microglia originate from the yolk sac as primitive macrophages, migrating into the fetal brain before the formation of the blood-brain barrier, and completing their maturation in the brain environment.(B) Acronyms used for the cell types in this study.(C) Co-culture of iPSC embryonic macrophages and iPSC-cortical neurons with IL-34 (and, optionally, low level GM-CSF) recapitulates development of microglia in the brain. White arrows: highly ramified cells most evident in dense neuron clusters.(D) Ramified microglia after 2 weeks of co-culture.Black scale bars, 200 μm; white scale bars, 50 μm. See also Figures S1 and S2; Movie S1.] We aimed to recapitulate the in vivo developmental pathway of microglia in vitro, using human induced pluripotent stem cells (iPSCs). These have the advantages of limitless self-renewal and normal karyotype, and can be directed to terminally differentiated cell types. They can be derived from patients (retaining the patient's genetic background) and are amenable to gene editing, enabling sophisticated interrogation of genes of interest. To recapitulate the development of yolk sac-derived macrophages, we use our previously established, straightforward, highly efficient, serum- and feeder-free protocol for deriving PSC macrophages (Karlsson et al., 2008, van Wilgenburg et al., 2013). We have recently directly demonstrated that these derive from MYB-independent, RUNX1- and PU.1-dependent precursors, characteristic of yolk sac-derived macrophages (Buchrieser et al., 2017, Vanhee et al., 2015). Here, we co-culture them with iPSC cortical neurons (Shi et al., 2012), in medium optimized for survival and functionality of both neurons and microglia. The resulting co-cultures are stable for many weeks, express relevant microglia markers (including key disease-related genes), upregulate pathways relating to homeostatic functions, and downregulate pathogen-response pathways. They are phagocytic, display highly dynamic ramifications, respond to activation by clustering and adoption of ameboid morphology, and produce cytokine profiles that are specific to co-culture versus monoculture. RESULTS iPSC-Derived Embryonic Macrophages Co-cultured with iPSC-Derived Neurons Recapitulate Microglial Development in the Embryo To recapitulate the development of microglia in the embryo (Figure 1A), we used our previously established protocol (van Wilgenburg et al., 2013) to generate embryonic-like, MYB-independent macrophage precursors from iPSCs from four different donors (Table S1). Defined-size embryoid bodies (EBs) are formed using Aggrewells (STEMCELL Technologies), cultured with bone morphogenetic protein 4 (BMP4; to induce mesoderm), vascular endothelial growth factor (VEGF; endothelial precursors), and stem cell factor (SCF; hematopoietic precursors), then plated into large-format flasks with IL-3 and macrophage colony-stimulating factor (M-CSF) to promote myeloid differentiation. Most EBs adhere, put out surrounding adherent stromal cells, and develop cystic, yolk-sac-like structures. After 3–4 weeks, embryonic-like macrophage precursors emerge into the supernatant